ELOXX PHARMACEUTICALS INC (ELOX)
US29014R2022 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to ELOX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 61.2. This target is 1502.09% above the current price.
ELOX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ELOX.
In the previous month the buy percentage consensus was at a similar level.
ELOX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-07-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-04-06 | Oppenheimer | Reiterate | Outperform |
| 2022-05-23 | Piper Sandler | Maintains | Overweight |
| 2022-05-09 | HC Wainwright & Co. | Maintains | Neutral |
| 2021-12-17 | Oppenheimer | Initiate | Outperform |
| 2021-11-18 | HC Wainwright & Co. | Maintains | Neutral |
| 2021-11-11 | HC Wainwright & Co. | Maintains | Neutral |
| 2021-06-30 | Mizuho | Initiate | Buy |
| 2021-05-27 | B. Riley Securities | Initiate | Buy |